共 110 条
- [1] Porter JM(1995)Reporting standards in venous disease - an update J Vasc Surg 21 635-645
- [2] Moneta GL(2012)Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline Dermatol Surg 38 1322-1330
- [3] Peterson JD(1999)Sclerotherapy for leg telangiectasia – a blinded comparative trial of polidocanol and hypertonic saline Dermatol Surg 25 381-386
- [4] Goldman MP(2013)Venous symptoms in C0 and C1 patients: UIP consensus document Int Angiol 32 261-265
- [5] Weiss RA(1974)Surgery and sclerotherapy in the treatment of varicose veins: a random trial Arch Surg 109 793-542
- [6] Duffy DM(2011)Sclerotherapy for lower limb telangiectasias Cochrane Database Syst Rev 12 CD008826-131
- [7] Fabi SG(2006)Injection sclerotherapy for varicose veins Cochrane Database Syst Rev 4 CD001732-336
- [8] Weiss MA(2000)Extensive tissue necrosis following high concentration sclerotherapy for varicose veins Dermatol Surg 26 535-316
- [9] Guiha I(2013)Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review Phlebology 28 123-190
- [10] McCoy S(1995)The Australian Polidocanol (Aethoxysklerol) Study - Results at 2 Years Dermatol Surg 21 334-1452